Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
AIDS Research and Human Retroviruses|August 2, 2008
Zidovudine/lamivudine/abacavir plus tenofovir in HIV-infected naive patients: a 96-week prospective one-arm pilot studyElena Ferrer, Jose Maria Gatell, Pochita Sanchez, et al.
Antiviral Therapy|December 15, 2015
Cerebrospinal fluid and plasma lopinavir concentrations and viral response in virologically suppressed patients switching to lopinavir/ritonavir monotherapy once dailyJuan M Tiraboschi, Hernando Knobel, Arkaitz Imaz, et al.
Enfermeria Clinica|January 26, 2008
[Access to the internet among nurses and type of information sought]Amparo Muñoz-Izquierdo, Amparo Puchades-Simó, Amparo Marco-Gisbert, et al.
BMC Cancer|July 2, 2025
STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's SarcomaClaudia A M Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|June 4, 2009
An intracardiac ectopic thyroid massSilvia Masmitjà Comajuan, Jorge López Ayerbe, Bernat Romero Ferrer, et al.
Echocardiography (Mount Kisco, N.Y.)|November 30, 2021
Prevalence and factors associated with atrial mitral and tricuspid regurgitation in patients with atrial fibrillationFrancisco Gual-Capllonch, Germán Cediel, Albert Teis, et al.
AIDS Research and Human Retroviruses|December 21, 2010
Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adultsElena Ferrer, Luis del Rio, Esteban Martínez, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2014
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trialJosé Moltó, Marta Valle, Elena Ferrer, et al.
Atherosclerosis|January 31, 2016
Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular riskMaria Saumoy, Carlos Alonso-Villaverde, Antonio Navarro, et al.
The Journal of Infectious Diseases|September 1, 2016
HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral RegimenArkaitz Imaz, Javier Martinez-Picado, Jordi Niubó, et al.
Pageof 12